Form 4: Crescent Capital CFO Buys 2,000 Shares

Sentiment:

Insider Transaction Report


Crescent Capital BDC's Chief Financial Officer, Gerhard Lombard, increased his stake by purchasing 2,000 shares of common stock at a weighted average price of $13.3415.

Better than expectedThe Chief Financial Officer's purchase of company stock signals strong insider confidence in Crescent Capital BDC's future.The transaction was executed under a Rule 10b5-1 plan, indicating a deliberate and pre-planned investment decision.The increase in the CFO's beneficial ownership, including shares from dividend reinvestment, further aligns management's interests with those of shareholders.

Summary

  • Gerhard Lombard, Chief Financial Officer of Crescent Capital BDC, Inc. (CCAP), acquired 2,000 shares of common stock.
  • The transaction occurred on November 17, 2025, at a weighted average price of $13.3415 per share, with prices ranging from $13.34 to $13.3499.
  • Following this purchase, Lombard's beneficial ownership increased to 34,284 shares of common stock.
  • The reported beneficial ownership includes 2,627 shares acquired through dividend reinvestment in 2025 that were not previously reported.
  • The transaction was executed pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 8

Explanation: The purchase of company stock by the Chief Financial Officer, especially under a Rule 10b5-1 plan, indicates strong confidence in the company's current valuation and future prospects. This is typically viewed very positively by investors.

Positives

  • Chief Financial Officer Gerhard Lombard's purchase of 2,000 shares indicates management confidence in the company's future prospects.
  • The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-planned and structured investment strategy.
  • The increase in beneficial ownership to 34,284 shares, including 2,627 shares from dividend reinvestment, demonstrates a growing alignment of management's interests with shareholders.

Negatives

  • No specific negative information is disclosed in this Form 4 filing.

Risks

  • No specific risks are mentioned in this Form 4 filing.

Future Outlook

NA

Industry Context

Insider purchases, especially by a Chief Financial Officer, are often interpreted by the market as a signal of management's confidence in the company's valuation and future performance. This transaction aligns with a broader trend where insider buying can precede positive company developments or reflect a belief that the stock is undervalued.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Transaction Plan DisclosureThe transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).11/17/2025This indicates a pre-arranged trading plan, which helps mitigate concerns about opportunistic insider trading and demonstrates a structured approach to equity transactions.

Stakeholder Impact

  • Shareholders: The purchase by a key executive may instill confidence among existing and potential shareholders, suggesting a belief in the company's value and future growth.
  • Employees: May view the CFO's investment as a positive sign of leadership's commitment to the company's success.

Key Dates

DateDescription
11/17/2025Date of earliest transaction (purchase of common stock)
11/18/2025Date of filing and signature by Reporting Person

Recommendation

buy

The Chief Financial Officer's decision to purchase additional shares, particularly under a Rule 10b5-1 plan, signals strong conviction in Crescent Capital BDC's intrinsic value and future performance. Insider buying is often a bullish indicator, suggesting that management believes the stock is undervalued or poised for growth. This action aligns management's interests more closely with shareholders and provides a compelling reason for investors to consider a 'buy' recommendation.

Keywords

Crescent Capital BDC, CCAP, Gerhard Lombard, Insider Trading, Form 4, Stock Purchase, CFO, Equity Acquisition, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.